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Fluorescence resonance energy transfer
Multidrug resistance
Nucleotide-binding domainved, the N-terminal nucleotide-binding domain (NBD) of Cdr1p and other fungal
transporters has some unique substitutions of amino acids which appear to have functional signiﬁcance for
the drug transporters. We have previously shown that the typical Cys193 in Walker A as well as Trp326 and
Asp327 in the Walker B of N-terminal NBD (NBD-512) of Cdr1p has acquired unique roles in ATP binding and
hydrolysis. In the present study, we show that due to spatial proximity, ﬂuorescence resonance energy
transfer (FRET) takes place between Trp326 of Walker B and MIANS [2-(4-maleimidoanilino) naphthalene-6-
sulfonic acid] on Cys193 of Walker A motif. By exploiting FRET, we demonstrate how these critical amino
acids are positioned within the nucleotide-binding pocket of NBD-512 to bind and hydrolyze ATP. Our results
show that both Mg2+ coordination and nucleotide binding contribute to the formation of the active site. The
entry of Mg2+ into the active site causes the ﬁrst large conformational change that brings Trp326 and Cys193
in close proximity to each other. We also show that besides Trp326, typical Glu238 in the Q-loop also
participates in coordination of Mg2+ by NBD-512. A second conformational change is induced when ATP, but
not ADP, docks into the pocket. Asn328 does sensing of the γ-phosphate of the substrate in the extended
Walker B motif, which is essential for the second conformational change that must necessarily precede ATP
hydrolysis. Taken together our results imply that the uniquely placed residues in NBD-512 have acquired
critical roles in ATP catalysis, which drives drug extrusion.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
In the human pathogenic yeast Candida albicans, overexpression of
the drug efﬂux pump encoding genes CDR1 and CDR2 belonging to the
ABC [1–7] and CaMDR1 belonging to MFS family of transporters is one
of the principal mechanisms of azole resistance [8–10]. Among ABC
transporters, Cdr1p has emerged as a major drug efﬂux protein in-
volved in azole resistance [6,11]. Thus, Cdr1p has not only acquired
signiﬁcant clinical importance but is also considered an important
target in any design of strategies to combat antifungal resistance [12].or Facilitator Superfamily; ATP,
cence resonance energy transfer;
acid; NBD, nucleotide-binding
mide; NBS,N-bromosuccinimide
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l rights reserved.Cdr1p, like othermembers of the ABC superfamily, has four distinct
modules: two TMDs consisting of six transmembrane segments and
two NBDs located on the cytosolic side of the membrane. The NBDs,
which couple energy of ATP hydrolysis to power drug export are
highly conserved throughout the evolutionary scale [2,1]. Each NBD
contains three characteristic motifs: Walker A and Walker B motifs,
which form the nucleotide-binding site [13], and an ABC signature
sequence, or C motif, for which several functions have been proposed,
including communication between the TMDs and NBDs during the
transport cycle [14].
Currently, there is very limited information regarding the struc-
tural architecture of NBDs of ABC proteins. For many ABC transporters
there is evidence that the two NBDs, although highly similar in
sequence, may adopt different functional roles in the transport cycle
[15,16]. A high-resolution crystal structure for the NBD subunit of
histidine permease (HisP) has its two catalytic sites facing away from
each other in the crystal dimer [17]. Jones and George, on the other
hand, proposed a model of interaction between the two NBDs in
which the Signature motif of one of the NBDs is directly involved in
ATP binding by the other and is important for catalysis [18]. A similar
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human P-gp, a close homologue of Cdr1p, the issue of functional
asymmetry of the two NBDs remains contentious with proposals both
in favor [19,20] and against [21–23] functional asymmetry.
In contrast to most ABC transporters, the NBDs of fungal
transporters, including Cdr1p, have unique positioning of a typical
Cys193 in Walker A of N-terminal NBDs as well as Trp326 and Asn328
in and adjacent to Walker B motifs, respectively [24]. Thus the
otherwise much conserved N-terminal NBDs of fungal transporters
have the distinction of unique positioning of typical amino acid
residues. On the other hand, the C-terminal NBD of Cdr1p and other
ABC fungal transporters possess perfectly conserved motifs, which are
essentially identical to those in non-fungal transporters as well [24].
Based on sequence analyses and these unique substitutions, it
was earlier suggested that the N-terminal NBD of Pdr5p from
S. cerevisiae is probably unable to perform ATP hydrolysis and that
the transporter might function with only one of its two NBDs [24].
Since Pdr5p is a close homologue of Cdr1p, we expected that such
a model, by extension, would be applicable to Cdr1p as well. How-
ever, we found that the NBDs in Cdr1p were functionally asym-
metric and the swapping of NBDs resulted in non-functional Cdr1p
chimeras, suggesting that the two NBDs were essential and non-
exchangeable [25]. Further, by purifying the N-terminal NBD of Cdr1p
in isolation, and generating several mutants, we have recently shown
in a series of papers that not only is this domain capable of ATPase
activity, but its unique amino acid substitutions also ﬁgure in this
functioning.
To begin deﬁning the functional signiﬁcance of the conserved
substitutions in N-terminal NBD of Cdr1p, we demonstrated that
replacement of the unique Cys193 with Ala gravely impaired ATP
hydrolysis without affecting its ability to bind the nucleotide [26,27].
On the other hand, substitution of Trp326with Ala resulted only in the
loss of ATP binding [28]. Substitution of the highly conserved, putative
catalytic residue, Asp327 with Asn yielded a mutant variant protein
with strongly impaired ATPase activity but comparable nucleotide
binding to that of the wild type protein. Thus Asp327 of Cdr1p, unlike
in other non-fungal ABC transporters, is a catalytic base and is unlikely
to be involved in Mg2+ coordination [28,29]. In each case, we backed
up results obtained from domain analysis by making the same
mutations in the full-length protein and showing that the mutations
actually do have a functional relevance.
The current paper deals with the mechanistic details of how the N-
terminal NBD of Cdr1p actually binds and hydrolyzes ATP. Using FRET
we show that there are two distinct conformational changes in this
domain that correspond to Mg2+ coordination and ATP binding,
respectively, and which are both important for the subsequent ATP
hydrolysis activity.Table 1
List of strains used in this study
Name Description
SJGN1-8P BL21(DE)pLysS cells carrying the pSJGN1-8 plasmid
VRGN W326A SJGN1-8P cells carrying the pVRGN W326A plasmid
VRGN D327A SJGN1-8P cells carrying the pVRGN D327A plasmid
VRGN D327N SJGN1-8P cells carrying the pVRGN D327N plasmid
VRGN CW4 SJGN1-8P cells carrying the pVRGN CW4 plasmid
VRGN E238A SJGN1-8P cells carrying the pVRGN E238A plasmid
VRGN E238Q SJGN1-8P cells carrying the pVRGN E238Q plasmid
VRGN E238D SJGN1-8P cells carrying the pVRGN E238D plasmid
VRGN N328E SJGN1-8P cells carrying the pVRGN N328E plasmid
VRGN N328A SJGN1-8P cells carrying the pVRGN N328A plasmid
SJGN C193A SJGN1-8P cells carrying the pSJGN mutC plasmid
VRGN C193S SJGN1-8P cells carrying the pVRGN C193S plasmid
VRGN CW4 N328A SJGN1-8P cells carrying the pVRGN CW4 N328A plasmid
VRGN CW4 D327N SJGN1-8P cells carrying the pVRGN CW4 D327N plasmid
VRGN CW4 D327A SJGN1-8P cells carrying the pVRGN CW4 D327A plasmid
VRGN CW4 E238A SJGN1-8P cells carrying the pVRGN CW4 E238A plasmid2. Experimental procedures
2.1. Materials
Disodium-ATP and ADP, NEM and DTE were purchased from Sigma Chemical Co.
MIANS was supplied by Molecular Probes.
2.2. Methods
2.2.1. Construction of mutant variant of NBD-512 by site directed mutagenesis
Site directed mutagenesis was performed using the quick-change site directed
mutagenesis kit (Stratagene, La Jolla, CA) as described previously [29]. Sequential Cys
and Trp mutations and other mutations were introduced into plasmid pSJGN1-8
according to the manufacturer's instructions, and sequentially mutated plasmid was
transformed in E. coli BL21 (DE3) pLysS cells listed in Table 1. Oligonucleotides used in
this study, as listed in Supplementary data Table TS1 were commercially procured from
Sigma Genosys, Inc. The presence and authenticity of the desired mutations were
conﬁrmed by dideoxy sequencing.
2.2.2. NBD-512 (NBD1) and its mutant variant's puriﬁcation and measurement of ATPase
activity
NBD-512 was puriﬁed from SJGN1-8 bacterial strain as described previously [26].
Mg2+ dependent ATPase activity of the puriﬁed NBD-512 was determined by assessing
the release of inorganic phosphate from ATP, as described previously [26] in the
presence of 5 mM ATP and 8 mM MgCl2 at 30 °C.
2.2.3. Labeling of puriﬁed NBD-512 and its mutant variants with MIANS
To carry out labeling of puriﬁed NBD-512, ~50 μg protein was incubated in ATPase
buffer (60 mM Tris–Cl pH 6.5 and 8 mMMgCl2) at 22 °C with 50 μMMIANS for 15 min.
Unreacted MIANS was quenched with 1 mM DTE. Control unlabelled NBD-512 protein
was obtained from the same puriﬁed protein preparation. All protein concentrations
were adjusted to ~50 μg/ml.
2.2.4. Resonance energy transfer measurements
Fluorescence intensities were measured at 22 °C in a 1 cm-path length cuvette
using Cary Eclipse Varian spectroﬂuorimeter with slit bandwidths of 5 nm for excitation
as well as emission. Measured ﬂuorescence intensities were corrected for dilution, for
buffer ﬂuorescence, contribution from free and protein-bound MIANS (this was
particularly important for Trp emission spectra and is detailed in the next section) and
for inner ﬁlter effect wherever required. Unless otherwise speciﬁed, 1 ml protein
samples (0.4 µM) in 60 mM Tris–HCl pH 6.5 containing 8 mM MgCl2 were used for the
ﬂuorescence experiments.
2.2.5. Determination of parameters for FRET analysis
The efﬁciency [E] of resonance energy transfer between the donor and acceptor can
be written as E=1−F/Fo, where F and Fo are the ﬂuorescence intensities of the donor in
the presence and absence of the acceptor, respectively. The spatial distance is given by:
R=Ro (E−1−1)1/6, where Ro is the Förster distance corresponding to 50% energy transfer.
Ro was calculated from Ro=(9.8×103) (Jκk2QDn−-4)1/6 (Å), where J is the spectral overlap
integral between donor and acceptor and was determined as in [30,31]; the orientation
factor κ2 was taken as 2/3; QD is the ﬂuorescence quantum yield of the donor, and n is
the refractive index of the medium, which was taken as 1.33 for dilute aqueous solution
[30]. Since MIANS labeling led to a red shift in the emission maximum of Trp
ﬂuorescence, we calculated the quantum yield of Trp in MIANS-labelled NBD-512 CW4
(NBD-512 CW4-MIANS) rather than in the unlabelled protein. For this, we corrected the
protein emission spectrum for contribution from protein-bound MIANS by obtaining
the spectrum of the MIANS-labelled protein after oxidation of its Trp residue using NBSPhenotype
Wild type functional and active
Decrease in ATP binding but can hydrolyze ATP with high KM and Vmax values
Loss in ATP hydrolysis
Loss in ATP hydrolysis
Functional like wild type
Decrease in ATP binding but can hydrolyze ATP with high KM and Vmax values
Functional albeit to a moderate level
Functional albeit to a moderate level
Loss in ATP hydrolysis
Loss in ATP hydrolysis
Loss in ATP hydrolysis
Loss in ATP hydrolysis but can hydrolyze ATP at high pH
Loss in ATP hydrolysis
Loss in ATP hydrolysis
Loss in ATP hydrolysis
Decrease in ATP binding can hydrolyze ATP with high KM and Vmax values
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The quantum yield QD, of Trp in NBD-512 CW4-MIANS was determined relative to a
standard, quinine sulphate (QS). The Trp emission of the labelled protein and QS in 0.1 N
H2SO4 were measured upon excitation at 295 nm. Both the sample and the standard
had the same absorbance (0.1) at 295 nm. The QD of NBD-512 CW4-MIANS was
calculated using the equation: QD=QNBD-512 CW4-MIANS=QQS×FNBD-512 CW4-MIANS /FQS,
where QQS, the quantum yield of quinine sulphate, was taken to be 0.51 in 0.1 N H2SO4
[30] and FNBD-512 CW4-MIANS and FQS are the integrals of the spectra of NBD-512
CW4-MIANS and QS, respectively, in the range of 310–500 nm. Estimated FRET
parameters are listed in Supplementary data Table TS2.
3. Results
Based on previous results, we hypothesized a model for ATP
hydrolysis by the N-terminal NBD (NBD-512) of Cdr1p involving the
role of typically placed residues such as Cys193 in Walker A as well
as Trp326, Asp327 and Asn328 in the Walker B and extended Walker
B motifs [29]. The conserved motifs and location of these typical
amino acids within them are shown in Fig. 1. However, so far experi-
mental data was insufﬁcient to suggest how these residues are placed
with respect to one another for binding and hydrolysis of ATP. To
this end, in the present study, we exploited FRET between critical
residues of NBD-512. The assumption was that if Trp326 and Cys193
are in close proximity to bind and hydrolyze ATP, respectively, one
should be able to monitor FRET between them by ﬂuorescently
labeling Cys193. The role of other conserved residues could also be
studied by monitoring the effect of their substitution mutations on
this FRET.
Due to the fact that NBD-512 possesses four additional Trp and Cys
residues and to avoid complications in interpretation of the FRET data,
we generated a mutant variant of NBD-512 (designated as NBD-512
CW4) in which all Cys and Trp residues with the exception of Cys193
and Trp326 were replaced with Ala. Having determined that NBD-512
CW4 bound ATP (Kd 0.072±0.04 mM) and hydrolyzed it (KM 0.185±Fig. 1. Sequence alignment of the conserved motifs from fungal ABC transporters. Compariso
motifs of N- and C-terminal NBD of Cdr1p with known (A) Fungal and (B) Non-fungal ABC tran
N-terminal NBD are marked.0.04 mM, Vmax 80±5 nmol/min/mg) in a manner comparable to NBD-
512, we used this mutant variant for further studies.
3.1. MIANS can selectively label Cys193 of NBD-512 CW4 mutant variant
MIANS selectively and covalently modiﬁes cysteine side chains
under appropriate conditions and becomes highly ﬂuorescent upon
binding to proteins [30,31]. The puriﬁed N-terminal NBD (NBD-512) of
Cdr1p has ﬁve Cys residues that could potentially react with MIANS.
Expectedly, the addition of MIANS to puriﬁed wild type NBD-512 led
to a rapid increase in the ﬂuorescence intensity at 450 nm in a
concentration dependent manner (Fig. 2A). Pretreatment of NBD-512
with NEM (another Cysmodifying agent) caused no further increase in
ﬂuorescence upon addition of MIANS, indicating that the two agents
compete for the same site(s) (data not shown).
When MIANS labeling was done with NBD-512 CW4, one could
speciﬁcally label Cys193. Similar to thewild type NBD-512, an increase
in the MIANS ﬂuorescence is observed in this mutant variant, albeit to
a lesser extent (Fig. 2C).
Sinceweknow fromour previous study that Cys193 is critical for ATP
hydrolysiswe expected that the presence of ATP prior toMIANS labeling
will physically block the access of the ﬂuorophore (Supplementary data
Fig. S1). A short pre-incubation with ATP resulted in reduction in the
extent of modiﬁcation of NBD-512 with MIANS (Fig. 2B). There was
practically no labeling with MIANS if NBD-512 CW4 was pre-
equilibrated with ATP (Fig. 2D). The importance of Cys193 in ATP
catalysis was further evidentwhenMIANS labelingwas donewithNBD-
512 C193A mutant variant in which Cys193 was mutated to Ala. It was
observed that MIANS could label the other cysteines of NBD-512 C193A
mutant variant, even after pretreatment with ATP (Fig. 2E and F). These
observations conﬁrmed that modiﬁcation by MIANS at Cys193 was
speciﬁcally susceptible to the presence of ATP.n of the sequence alignment of the Walker A, Q-loop, signature C, Walker B and H-loop
sporters. Conserved but unique residues Cys193, Glu238, Trp326, Asp327 and Asn328 of
Fig. 2. Fluorescence emission spectra of MIANS-labelled NBD-512, and the effect of ATP on labeling. Samples containing 0.4 μM protein samples in ATPase buffer were excited at 322 nm.
Emission spectra were recorded between 400 and 500 nm. Fluorescence emission spectra of NBD-512 and its mutant variant were measured in presence of increasing concentrations of
MIANS (curve 1 (1.0 μM), curve 2 (5.0 μM), curve 3 (10 μM), curve 4 (25 μM) and curve 5 (50 μM)). In the presence of 10 mM ATP, partial protection of Cys residues of NBD-512, complete
protectionof Cys193 inNBD-512CW4andnoprotectionofCys residues ofNBD-512C193Amutant variants frommodiﬁcationbyMIANSwereobserved. Fluorescence spectrumuponMIANS
labeling (A) in the absence ofATPwithNBD-512 (B) afterpre-incubation ofNBD-512with 10mMATP (C) in the absenceofATPwithNBD-512CW4mutant variant (D) after pre-incubation of
NBD-512CW4mutant variantwith10mMATP (E) in the absenceofATPwithNBD-512C193Amutant variantand (F) afterpre-incubationofNBD-512C193Amutantvariantwith10mMATP.
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MIANS labeling results in ~5 nm red shifted emission for Trp326 in
NBD-512 CW4-MIANS, suggesting that the probe does perturb the
nucleotide-binding pocket of the protein. However, our results show
that both NBD-512-MIANS and NBD-512 CW4-MIANS continue to
sense Mg–ATP docking, exhibiting a concentration dependent,
saturable quenching of MIANS ﬂuorescence upon titration with Mg–
ATP (Fig. 3A and B). The Kd for Mg–ATP binding to NBD-512-MIANS as
well as NBD-512 CW4-MIANS was effectively unaltered (Fig. 3C) [28].
Very similar Kd values were obtained upon titration with Mg–ADP as
well (NBD-512-MIANS, 0.07±0.03 mM; NBD-512 CW4-MIANS, 0.07±0.04 mM). Thus, it was possible to extrapolate the information from
ATP binding to NBD-512 CW4-MIANS to understand how NBD-512
might function. Of note, ATP caused no shift in MIANS emission
maximum in NBD-512-MIANS or NBD-512 CW4-MIANS, indicating
that the polarity of the environment around MIANS in either variants
remained effectively unaltered.
3.3. Energy transfer occurs between Trp326 and MIANS-labelled Cys193
The ﬂuorescence emission spectrum of Trp326 has a signiﬁcant
degree of overlap with the absorption spectrum of MIANS (λex, λem for
tryptophan is 295 and 340 nm; λex, λem for MIANS is 322 and 450 nm).
Fig. 4. Fluorescence resonance energy transfer between the donor (Trp) and acceptor
(MIANS) in NBD-512 and NBD-512 CW4. Puriﬁed 0.4 μM NBD-512 (A) or NBD-512 CW4
(B) mutant variant in ATPase buffer was titrated with increasing concentrations of
MIANS (0–50 μM), incubated for 2 min after addition of each aliquot and emission
spectra recorded between 310 and 500 nm.
Fig. 3. ATP binding with MIANS-labelled NBD-512 and its mutant variant NBD-512 CW4
monitoring extrinsic MIANS ﬂuorescence. To achieve complete labeling, samples contain-
ing 0.4 μM protein in ATPase buffer were incubated with 50 μM MIANS for 15 min.
Fluorescence spectrawere recorded upon excitation at 322 nmand emissionwas recorded
between 400 and 500 nm. (A) Fluorescence emission spectra of MIANS-labelled NBD-512
inpresenceof increasing concentrations of ATP (curve 1, noATP; curve 2, 0.05mM; curve 3,
0.2 mM; curve 4, 0.5 mM; curve 5, 1.0 mM). (B) Fluorescence emission spectra of MIANS-
labelled NBD-512 CW4mutant variant measured in presence of increasing concentrations
of ATP (curve 1, no ATP; curve 2, 0.5 mM; curve 3, 1.0 mM). (C) Concentration dependent
binding of ATP to the MIANS-labelled NBD-512 (●) and its mutant variant NBD-512
CW4 (○). Normalized ﬂuorescence intensity (Fo/Fc) was plotted as a function of ATP con-
centration, where Fo refers to the ﬂuorescence intensity of the sample in absence of ATP
and Fc represents the ﬂuorescence emission intensity at 450 nm upon ATP addition
(background corrections as mentioned under Methods). The plot represents averages of
three different experiments done in duplicates. The bars represent standard deviations.
From the slope and ordinate of the Scatchard plot (plot not shown), dissociation constant
(Kd) for ATP bindingwas determined to be 0.07±0.03mM for NBD-512 and 0.08±0.04mM
for NBD-512 CW4 assuming a single binding site per molecule.
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using FRET. Since MIANS could label Cys193 of NBD-512 CW4, it could
form a donor–acceptor pair with Trp326 provided the ﬂuorophores laywithin close proximity to each other. To test this, puriﬁedNBD-512 and
NBD-512 CW4, in a buffer containing Mg2+, were separately excited at
295 nm in the presence of increasing concentrations of MIANS, and
ﬂuorescence emission recorded between 310–500 nm (Fig. 4A and B,
respectively). We observed a sharp increase in ﬂuorescence emission
of protein-boundMIANS at 450 nm; theﬂuorescence emission of Trp at
340 nm was simultaneously quenched. This effect, due to resonance
energy transfer, was concentration dependent.
Trp emissionwas also ~5 nm red shifted, suggesting that Trp326 in
NBD-512 CW4 becomes more solvent-exposed upon incorporation of
MIANS. Hence, to obtain reliable estimates of Förster's radius and
spatial distances between the two ﬂuorophores, it was important to
differentiate between quenching as a result of change in polarity of the
environment around Trp from that due to FRET [Supplementary data
Table TS2]. For this purpose, we subtracted from the emission spec-
trum of NBD-512 CW4-MIANS a spectrum of the protein after treat-
ment with NBS as described under Methods. The resultant spectrum
was taken as that of Trp326 alone in NBD-512 CW4-MIANS.
3.4. FRET monitors conformational changes induced by Mg2+
We showed previously that Mg–ATP causes a signiﬁcant conforma-
tional change in NBD-512 [28]. However, whether the conformational
changes were the result of metal ion coordination or due to nucleotide
docking was not apparent from that study [28]. By exploiting FRETand
NBD-512 CW4 mutant variant, we re-addressed this issue. Interest-
ingly, in thepresence of EDTA andnoMg2+, poor FRETwas seen inNBD-
512 CW4 upon titration with MIANS (Fig. 5A). MIANS on Cys193 of
NBD-512 CW4 was estimated to be at a distance of ~25 Å from Trp326
in the presence of EDTA (Table 2).
Table 2







NBD-512 CW4 No MgCl2 24.5 Å 20.0±2.5
NBD-512 CW4 10 mM MgCl2 18.2 Å 60.0±1.2
NBD-512 CW4 5 mM Mg–ATP 11.9 Å 95.0±1.2
NBD-512 CW4 5 mM Mg–ADP 14.1 Å 85±1.8
NBD-512 CW4 D327N No MgCl2 25.1 Å 18±2.1
NBD-512 CW4 D327N 10 mM MgCl2 18.4 Å 58.0±1.4
NBD-512 CW4 D327N 5 mM Mg–ATP 12.1 Å 94.5±1.1
NBD-512 CW4 D327N 5 mM Mg–ADP 14.9 Å 83.2±1.0
NBD-512 CW4 E238A No MgCl2 24.8 Å 20±1.9
NBD-512 CW4 E238A 10 mM MgCl2 19.7 Å 48.0±1.0
NBD-512 CW4 E238A 5 mM Mg–ATP 17.5 Å 65.0±1.7
NBD-512 CW4 E238A 5 mM Mg–ADP 17.7 Å 64.0±1.8
NBD-512 CW4 N328A No MgCl2 24.2 Å 19±1.9
NBD-512 CW4 N328A 10 mM MgCl2 18.0 Å 61.1±1.0
NBD-512 CW4 N328A 5 mM Mg–ATP 14.4 Å 86.0±1.5
NBD-512 CW4 N328A 5 mM Mg–ADP 14.4 Å 85.6±1.5
Mg2+ was added prior to ATP/ADP addition. No nucleotide binding was seen in the
absence of Mg2+ as discussed in the text.
Fig. 5. Effect of Mg2+ ion on FRET. Puriﬁed 0.4 μM NBD-512 CW4 or mutant variants in
Mg2+ free ATPase buffer (60 mM Tris–Cl pH 6.5) were incubated with 50 μM MIANS for
15 min. After labeling, the samples were titrated with increasing concentrations of MgCl2
(0–10mM) and emission spectrawere recorded between 310 and 500 nmupon excitation
at 295 nm. (A) Fluorescence emission spectra of NBD-512 CW4-MIANS mutant variant in
presence of increasing concentrations of MgCl2 (curve 1, unlabelled protein, curve 2, no
MgCl2 with 8 mM EDTA; curve 3, 5 mM MgCl2; curve 4, 10 mM MgCl2). (B) Fluorescence
emission spectra of MIANS-labelled NBD-512 CW4 D327N mutant variant in presence of
increasing concentrations of MgCl2 (curve 1, unlabelled protein, curve 2, no MgCl2 with
8 mM EDTA; curve 3, 7.5 mM MgCl2; curve 4, 10 mM MgCl2). (C) Fluorescence emission
spectra of MIANS-labelled NBD-512 CW4 N328Amutant variant in presence of increasing
fractions ofMgCl2 (curve 1, unlabelledprotein, curve 2, noMgCl2with 8mMEDTA; curve 3,
3mMMgCl2; curve 4,10mMMgCl2). Efﬁciencies of Energy transferwere calculated for the
change in ﬂuorescence from curve 2 to curve 4 in each case.
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MIANS ﬂuorescence in NBD-512 CW4 (Fig. 5A; Table 2). This further
conﬁrms that Trp326 andMIANS on Cys193 arrivewithin greater spatial
proximity (18.2 Å) once Mg2+ is coordinated within the nucleotide-
binding pocket. That such a conformational change is essential for ATP
hydrolysis is clear since the domain is incapable of catalysis in the
absence of themetal ion [26,28]. Further, addition of ATP in the absence
of the metal ion could not cause any signiﬁcant effect on FRET,
suggesting that binding of Mg2+ was a prerequisite for ATP binding. It
may also be noted that Mg2+ did not affect the ﬂuorescence of MIANS
itself in NBD-512 CW4 (data not shown). Hence, it appears unlikely that
Cys193 has a direct role in Mg2+ coordination.We had earlier observed that NBD-512 C193Amutant variant binds
ATP in a manner similar to wild type and has similar degrees of
accessibility to small molecular weight ﬂuorescence quenchers [28].
The Kd for ATP calculated from changes in ﬂuorescence of NBD-512
CW4-MIANS also supports this contention that the protein can bind
Mg–ATP even when the Cys193 is labelled by MIANS (Fig. 3C).
It should be pointed out that the probe led to a slight perturba-
tion of the pocket. This, along with the fact that the probe itself is
roughly 10 Å in length [31] implies that the distances estimated here
should not be taken as the exact spatial distance between Trp326 and
Cys193 in the unlabelled protein. Notwithstanding this, the estimated
distances between the two ﬂuorophores certainly provide a useful
handle for monitoring conformational changes occurring upon ligand
binding.
Of note, we observed that another mutant variant, NBD-512 CW4
D327N, crippled in ATP hydrolysis showed conformational change and
FRET similar to NBD-512 CW4when titrated with Mg2+ (Fig. 5B). NBD-
512 CW4 D327A too behaved very much like NBD-512 CW4 D327N
(Supplementary data Fig. S2). This reconﬁrmed our previous results
that the conserved Asp at position 327, unlike its conventional role,
does not participate in metal ion coordination (Table 2). Likewise, the
catalytically deﬁcient mutant variant NBD-512 CW4 N328A too ex-
hibited FRET comparable to NBD-512 CW4 mutant variant with Mg2+
(Fig. 5C; Table 2), suggesting that Asn328 also had no direct role in
Mg2+ coordination.
3.5. Glu238 also coordinates Mg2+
Because of the unique placements of residues such as Cys193,
Trp326, Asp327 and Asn328 in N-terminal NBD of Cdr1p, it appears
that the conventional residues are not involved in Mg2+ coordination.
We already knew that the abstraction of metal ion directly affects the
ﬂuorescence spectrum of Trp in NBD-512 [28]. Titration with Mg2+,
results in an enhancement of the Trp ﬂuorescence intensity for NBD-
512 [28] as well as for NBD-512 CW4 (data not shown). Thus, Trp326
itself appears to be important for Mg2+ coordination and the
consequent conformational change in NBD-512. Yet all our previous
as well as current FRET results indicate that Trp326 alone cannot be
responsible for Mg2+ coordination. Results from other NBDs of ABC
transporters indicate that the commonly occurring glutamine of Q-
loop plays an important role either in contacting the γ-phosphate or
in interdomain communication [33,34]. In ButCD the conserved Gln in
the Q-loop (Gln80) has also been shown to be involved in metal ion
coordination [35].
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a typical substitution for all fungal transporters (Fig. 1). As expected,
mutant variants NBD-512 E238A and NBD-512 CW4 E238A were
impaired in ATP binding as well as ATPase activity (Fig. 6A and B).
Further, FRET analysis showed that this protein underwent a lesser
than expected conformational change upon Mg2+ addition (Fig. 6C;
Table 2). Thus, the mutation of Glu238 speciﬁcally impaired the ability
of the protein to sense the metal ion. It may be mentioned here that,
since Trp326 is intact, metal ion coordination is diminished but not
abolished and hence some FRET is expected in this mutant variant.
Replacement with a residue capable of metal ion coordination,
as in NBD-512 E238Q and NBD-512 E238D allowed Mg2+-ATP binding
in a manner comparable to NBD-512 and NBD-512 CW4 proteins
[Kd for NBD-512 E238Q was 0.08±0.01 mM and NBD-512 E238D was
0.07±0.01 mM]. Thus, the uncommon Glu238, is also involved in Mg2+
coordination.
Of note, the loss of activity in some of the mutant variants of NBD-
512was not due to their inability to formhomodimer; our results show
that NBD-512 is a monomer in solution (Supplementary data Fig. S3).
3.6. ATP docking subsequent to Mg2+ coordination induces further
conformational changes
Having shown that Mg2+ signiﬁcantly reduces the distance between
Trp326 and Cys193, we checked whether any further enhancement in
FRETwould occur on addition of ATP. Interestingly, ATP brought the twoFig. 6. Functional properties of NBD-512 CW4 E238A. (A) Concentration dependent binding o
E238A (▿) mutant variant. Normalized ﬂuorescence intensity (Fo/Fc) was plotted as a functi
absence of ATP and Fc represents the ﬂuorescence emission intensity at 450 nm upon A
experiments done in duplicates. The bars represent standard deviations. From the slope and o
was determined to be 0.49±0.03mM for NBD-512 E238A, 0.08±0.04mM for NBD-512 CW4 a
(B) Lineweaver–Burk plots of dependence of ATPase activity of NBD-512 CW4 and NBD-512
NBD-512 CW4 E238A at 30 °C for 30 min was carried out using different concentrations o
curves was used to obtain Lineweaver–Burk plots of the ATPase activity for NBD-512 CW4 (
80.2±6.0 nmol min−1 mg protein−1 and KMwas 120±4 µM. For NBD-512 CW4 E238A, Vmax wa
shown is average of three different experiments done in triplicates.(C) Fluorescence emission
increasing concentrations ofMgCl2 (curve 1, unlabelled protein alone, curve 2, with 8mMEDT
spectra of MIANS-labelled NBD-512 CW4 E238A mutant variant measured in presence of inc
MgCl2 andNoATP; curve 3,10mMMgCl2 and 5mMATP). Efﬁciency of energy transferwas calc
3 in the latter case.ﬂuorophores even closer and the R for NBD-512 CW4 was reduced by
~6Å (Fig. 7A; Table 2). ADP, on theotherhand, causes a smaller change in
distance (~4 Å) between the two (Fig. 7B; Table 2). A similar effect was
observed for the catalysis deﬁcient mutant NBD-512 CW4 D327N
(Fig. 7C and D; Table 2), further conﬁrming that unlike other ABC
transporters, the conserved Asp327 in NBD 512 is not involved in Mg2+
coordination nor important for ATP binding [29]. Expectedly, NBD-512
CW4 E238A, which is affected in Mg2+ binding, also shows poor
conformational change upon ATP/ADP addition (Fig. 6D).
In comparison to ATP, the inability of ADP to further induce FRET
emphasizes the role of γ-phosphate in the docking of the substrate. In
other words, the presence of Mg–ADP results in a more open con-
formation for the binding pocket as compared to when the substrate
Mg–ATP docks in. Thus, the formation of a functional nucleotide-
binding pocket is dictated both by the metal ion as well as by the
nucleotide itself.
3.7. Asn328 is a γ-phosphate sensor
How does this nucleotide-binding domain discriminate between
ATP and ADP? For this purpose we examined the role of vicinal
residues of Trp326 and Cys193. In particular, we were interested in
Asn328 that is again unique to N-terminal NBDs of fungal ABC
transporters (Fig. 1) and which we have previously shown to be
important for the ability of the protein to impart drug resistance to the
cell [29].f ATP to the MIANS-labelled NBD-512 CW4 (○) NBD-512 CW4 E238A (●) and NBD-512
on of ATP concentration, where Fo refers to the ﬂuorescence intensity of the sample in
TP addition (corrected for dilution). The plot represents averages of three different
rdinate of the Scatchard plot (plot not shown), dissociation constant (Kd) for ATP binding
nd 0.47±0.05mM for NBD-512 CW4 E238A, assuming a single binding site per molecule.
CW4 E238A mutant variant on substrate: ATPase assay for NBD-512 CW4 and mutant
f substrate (0–5 mM, as described under Methods). The linear portion of the activity
●) and mutant NBD-512 CW4 E238A (○). For NBD-512 CW4, Vmax was estimated to be
s estimated to be 150.3±4.0 nmol min−1 mg protein−1 and KMwas 650±15 µM. The data
spectra ofMIANS-labelled NBD-512 CW4 E238Amutant variantmeasured in presence of
A and noMgCl2; curve 3, 5mMMgCl2; curve 4,10mMMgCl2). (D) Fluorescence emission
reasing concentrations of ATP (curve 1 with 8 mM EDTA and no MgCl2; curve 2, 10 mM
ulated for the change inﬂuorescence fromcurve 2 to curve 3 in the former and curves 1 to
Fig. 7. Effect of ATP/ADP on FRET. Puriﬁed 0.4 μM NBD-512 CW4 or mutant variant in ATPase buffer were labelled using 50 μM MIANS for 15 min. After labeling, the samples were
titrated with increasing molar fractions of ATP (0–10 mM) and emission spectra were recorded between 310 and 500 nm (slit width 5 nm) upon excitation at 295 nm (slit width
5 nm). (A) Fluorescence emission spectra of MIANS-labelled NBD-512 CW4mutant variant measured in presence of increasing concentrations of ATP (curve 1 with 8mM EDTA and no
MgCl2, curve 2, 10 mMMgCl2 and no ATP; curve 3, 10 mMMgCl2 and 2.5 mM ATP; curve 4, 10 mMMgCl2 and 5 mM ATP). (B) Fluorescence emission spectra of MIANS-labelled NBD-
512 CW4mutant variant measured in presence of increasing concentrations of ATP (curve 1 with 8mM EDTA and noMgCl2; curve 2,10mMMgCl2 and no ADP; curve 3,10 mMMgCl2
and 2.5 mM ADP; curve 4, 10 mM MgCl2 and 5 mM ADP). (C) Fluorescence emission spectra of MIANS-labelled NBD-512 CW4 D327N mutant variant measured in presence of
increasing concentrations of ATP (curve 1 with 8 mM EDTA and noMgCl2, curve 2,10 mMMgCl2 and no ATP; curve 3, 10 mMMgCl2 and 3.5 mMATP; curve 4,10mMMgCl2 and 5mM
ATP). (D) Fluorescence emission spectra of MIANS-labelled NBD-512 CW4 D327Nmutant variant measured in presence of increasing concentrations of ADP (curve 1 with 8mM EDTA
and noMgCl2; curve 2,10mMMgCl2 and no ADP; curve 3,10mMMgCl2 and 3.5mMADP; curve 4,10mMMgCl2 and 5mMADP). (E) Fluorescence emission spectra of MIANS-labelled
NBD-512 CW4 N328A mutant variant measured in presence of increasing concentrations of ATP (curve 1 with 8 mM EDTA and no MgCl2, curve 2, 10 mMMgCl2 and no ATP; curve 3,
10 mM MgCl2 and 2.5 mM ATP; curve 4, 10 mM MgCl2 and 5 mM ATP). (F) Fluorescence emission spectra of MIANS-labelled NBD-512 CW4 N328A mutant variant measured in
presence of increasing concentrations of ADP (curve 1 with 8 mM EDTA and no MgCl2; curve 2, 10 mM MgCl2 and no ADP; curve 3, 10 mM MgCl2 and 2.5 mM ADP; curve 4, 10 mM
MgCl2 and 5 mM ADP). Note: In each case efﬁciency of energy was calculated from curves 1 to 4.
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Mg–ATP suggested that NBD-512 N328E or NBD-512 N328A bound
Mg–ATPwith an afﬁnity similar to NBD-512. So did themutant variant
NBD-512 CW4 N328A [Kd for NBD-512 N328E (0.08±0.01 mM); NBD-
512 N328A (0.08±0.01 mM)].That NBD-512 CW4 N328A continues to bind Mg2+ can also be
deduced from the R value obtained (Table 2). However, unlike NBD-
512 CW4, the mutant variant NBD-512 CW4 N328A exhibits a smaller
conformation change upon ATP docking (Fig. 7E; Table 2). Indeed,
despite proper Mg2+ coordination, NBD-512 CW4 N328A does not
Fig. 8.Hypothetical model for catalytic cycle of N-terminal active site of Cdr1p. Step I: Coordination of Mg2+ by Trp326 of theWalker BMotif and Glu238 of Q-loop of NBD-512 induces
the ﬁrst conformational change. Step II: ATP docking and γ-phosphate sensing by Asn328 of the extendedWalker Bmotif of NBD-512 induces the second conformational change. Step
III: ATP hydrolysis by the concerted action of Asp327 of Walker B and Cys193 of the Walker A motif. Step IV: Release of phosphate and ADP and active site is relaxed. Note: All the
distances mentioned in the ﬁgures, tables and text are calculated between MIANS labelled on Cys193 and Trp326 of NBD-512 of Cdr1p.
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also explain its inability to hydrolyze ATP. Thus, Asn328 appears to be
a sensor of the γ-phosphate of ATP and the subsequent conforma-
tional change therefore critical for catalysis.
It may also be pointed out here that a great deal of debate has taken
place on the role of the equivalent Glu residue at this position in other
ABC transporters that has also been shown to be essential for ATPase
activity. It had been suggested that the Glu acts as a general or catalytic
base [36]. However, Schmitt et al. have pointed out that this may
not be the whole story since converting it to Gln in other ABC trans-
porters led to varying degrees of ATPase activity [36]. We have
previously shown that the Asp327 adjacent to Asn328 had taken on
the catalytic role reserved for the glutamate in other systems. Our
results suggest that Asn328 too has acquired a new role, as a sensor of
the γ-phosphate. Given that in NBD-512 several residues have taken
on new roles, this is perhaps an extension of this trend.
4. Discussion
Besides demonstrating the essentiality of the two NBDs, we have
also shown the functional asymmetry of the two NBDs in Cdr1p
[25,37], and unequivocally shown that the unique substitutions in the
N-terminal domain have signiﬁcance for ATP hydrolysis by the domain
and to the functioning of the full protein in the cell [26–29]. Using
isolated N-terminal NBD (NBD-512) of Cdr1p which probably func-
tions as monomer andmaking the corresponding mutations in the full
protein, we showed that Cys193 in Walker A and Asp327 in Walker B
motifs of NBD-512 are both essential for ATP hydrolysis [26,28,29].
Further, we showed that Asp327 could act as a catalytic base since
replacement by Asn resulted in interesting pH effects on ATP
hydrolysis [29]. ATP binding by NBD-512 requires Mg2+ as well as
the presence of Trp326 in the Walker B motif of binding pocket [28].ATP binding to NBD-512 induces a conformation change, which is
speciﬁc to Mg–ATP docking rather than ATP hydrolysis in the wild
type NBD-512 [28]. This was supported by the fact that the catalysis
defunct mutant variants, NBD-512 C193A and NBD-512 D327N
continued to exhibit conformational change upon ATP binding similar
to native NBD-512 [28]. Together these results suggested that the
typical residues work in conjunction and contribute physically to the
active site formation [26,28,29]. Thus the N-terminal NBD of Cdr1p
and, by extension those of other fungal transporters like Pdr5p, have
evolved so as to use their unique substitutions to perform the task of
ATP binding and hydrolysis [26,28].
In the current study we have attempted to obtain greater
mechanistic details of the mechanism of ATP hydrolysis owing to
the unusual substitutions within this otherwise conserved domain. By
employing FRET, we have resolved the issues related to Mg2+ coor-
dination and ATP binding in the N-terminal NBD of Cdr1p. For this
purpose, we generated a mutant variant NBD-512 CW4 that had a
single Cys (193) and a single Trp (326). We also established that this
mutant variant functioned similar to thewild type NBD-512 protein as
far as ATP binding and hydrolysis was concerned.
Using this mutant variant, we for the ﬁrst time conﬁrm that both
Mg2+ and nucleotide binding contribute to the formation of the active
site in the domain. The entry of Mg2+ into the active site causes a ﬁrst
large conformational change that brings Trp326 and Cys193 into close
proximity. Further, Mg2+ has a distinct effect not only on FRET between
Trp326 and the MIANS on Cys193, but also causes an enhancement of
the intrinsic ﬂuorescence of Trp326 in the mutant variant NBD-512
CW4. Thus Trp326 plays a signiﬁcant role in Mg2+ coordination, which
in turn induces a conformational change within the domain. Our FRET
results further show that the typically conserved Glu238 of Q-loop of
NBD-512, is another residue involved in coordination of the metal ion
since its substitution as in NBD-512 CW4 E238A does not allow Trp326
2152 V. Rai et al. / Biochimica et Biophysica Acta 1778 (2008) 2143–2153and Cys193 to move sufﬁciently close in the nucleotide-binding
pocket despite the presence of Mg2+. Thus the uniquely placed Glu238,
which replaces Gln in the N-terminal NBD of all fungal ABC trans-
porters, takes over the role of Mg2+ coordination. On the other hand,
the uniquely placed Asn328, which is also common to all fungal
transporters, acts primarily as a γ-phosphate sensor and is responsible
for the second conformational change that occurs upon ATP binding.
Taken together, one can visualize a three-step mechanism of ATP
catalysis at NBD-512. Theﬁrst step occurswhenMg2+ enters the pocket
and contacts Trp326 of Walker B and Glu238 of Q-loop (Fig. 8 Step I).
This induces a conformational change that drags Cys193 of theWalker
A motif towards the catalytic pocket. As a result, Trp326 and Cys193
come within close proximity (R decreases to ~18.2 Å from 24.5 Å).
Subsequently, a second conformational change occurswhenATP docks
with its phosphates directed towards the pocket. Such a positioning
automatically brings the γ-phosphate close to the uniquely placed
Asn328 residue in the extended Walker B motif. The sensing of the γ-
phosphate by Asn328 is responsible for the second small but
signiﬁcant conformational change in the NBD. As a result Cys193
comes even closer to Trp326 (R~12 Å; Fig. 8 Step II). This sensing of the
γ-phosphate and closing in of the Walker A and Walker B motifs
towards the substrate constitutes an important event preceding ATP
hydrolysis. The third step is the actual catalysis step in which the
catalytic residues, Cys193 of Walker A and Asp327 of Walker B,
participate (Fig. 8 Step III). Thereafter, the protein has a more open
conformation (R is ~14 Å in the presence of Mg–ADP) that allows ADP
to leave.
As mentioned earlier, we have previously shown that Asp326 acts
as a catalytic base in ATP hydrolysis [29]. In order to understand the
role of Cys193 in the catalysis, we generated the mutant variant NBD-
512 C193S. In thismutant, Cyswas replaced by Serwhose hydroxyl has
a higher pKa than the thiol. At pH 6.5, this mutant variant has ~20% the
activity of the wild type protein, NBD-512. However, at pH 8.5 it
showed equal if not better ATPase activity as compared to NBD-512,
suggesting that the abstraction of the proton too is an essential step in
the ATPase activity (Supplementary data Fig. S4A and S4B).
As also deduced from data available for other ATPases [17,33,38],
we therefore suggest the following catalytic mechanism: Asp327
acting as a catalytic base abstracts a proton from a water molecule
present in the active site as part of the Mg–ATP complex. The hydroxyl
ion thus formed attacks at the γ-phosphate allowing the bond
between the γ- and β-phosphates to weaken and in turn allowing the
β-phosphate to abstract a proton from the –SH of Cys193 (Fig. 8 Step
III). The consequence of the proton abstraction is the cleavage of the
phosphodiester bond between β- and γ-phosphates, allowing the
latter to leave. After ATP is hydrolyzed, the conformation of the active
site relaxes back to a more open one since Asn328 cannot sense the β-
phosphate of ADP (Fig. 8 Step IV).
The fact that the isolated NBD possesses intrinsic ATPase activity is
interesting, particularly in the context of the coordinated functioning
of the NBDs in ABC transporters that has been frequently proposed. In
Cdr1p too we have reported the asymmetry of the NBDs, suggesting a
concerted mechanism of action. How do we account for this apparent
disparity? There can be several hypotheses. The isolated domain
contains within it all the requisites for intrinsic ATPase activity.
However, it is possible that the NBDs show positive cooperativity with
respect to ATP hydrolysis when the Signature sequence of one
interacts with the ATP bound state of the other. There are several
reports to suggest that the conserved Gln in the LSGGQ motif of the
second NBD is important for the formation of the catalytic site in the
ﬁrst. Mutational studies in MalK, for example, indicate that this Gln is
not a catalytic residue but could ‘stimulate’ ATPase activity [39]. It is
quite likely that ATP docking in the active site is sensed not only by the
Asn328 but also perhaps by one or more residues in the LSGGQ motif
of the second NBD as shown in the molecular dynamics simulation for
MJ7096 [40,41]. It is possible too that this recognition and subsequentconformational change/interdomain interactions are responsible for
the positive cooperativity in ATP hydrolysis. Another equally likely
scenario is that the accessibility of ATP to the active site of one of the
NBDs may be regulated by the other via steric considerations. How-
ever when drug binds to Cdr1p, conformational changes in the TM
domains are sensed by one of the NBDs and the signal is transduced to
the second NBD via the Signature sequence of the former.When ATP is
bound/hydrolyzed in this second NBD, it allows the domain to swing
out, a conformational change that is transduced to the ﬁrst NBD via
the Signature sequence of the second. Such a sequence of events could
also be cooperative and require a concerted action of both NBDs with
neither half being capable of functionally replacing the other.
Like the other motifs in the N-terminal NBDs, the ABC signature
sequences of Cdr1p and other fungal transporters too appear to have
diverged away from that of other ABC transporters. Whether this
became necessary to compensate for the substitutions in their N-
terminal NBDs or whether they have evolved a new mechanism for
coming together for ATP hydrolysis and drug efﬂux, is a question we
are currently examining.
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